FATE – Fate Therapeutics, Inc.
Fate Therapeutics, Inc.FATE
$1.00Name : Fate Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $114,604,000.00
EPSttm : -1.64
Fate Therapeutics, Inc.
$1.00
6.54%$0.07Float Short %
12.89
Margin Of Safety %
Put/Call OI Ratio
0.26
EPS Next Q Diff
-0.07
EPS Last/This Y
0.18
EPS This/Next Y
0.21
Price
1
Target Price
6.56
Analyst Recom
2.42
Performance Q
-17.36
Relative Volume
0.9
Beta
2.22
Ticker: FATE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | FATE | 0.9152 | 0.08 | 0.54 | 6175 |
| 2025-04-15 | FATE | 1.12 | 0.09 | 0.11 | 6458 |
| 2025-04-16 | FATE | 1.05 | 0.10 | 58.80 | 6379 |
| 2025-04-17 | FATE | 1.12 | 0.15 | 0.00 | 6667 |
| 2025-04-18 | FATE | 1.11 | 0.15 | 0.00 | 6667 |
| 2025-04-21 | FATE | 1.26 | 0.10 | 5.88 | 6332 |
| 2025-04-22 | FATE | 1.38 | 0.28 | 0.04 | 7578 |
| 2025-04-23 | FATE | 1.34 | 0.28 | 0.00 | 7590 |
| 2025-04-24 | FATE | 1.36 | 0.27 | 0.00 | 7796 |
| 2025-04-25 | FATE | 1.28 | 0.26830458835015 | 0 | 7795 |
| 2025-04-28 | FATE | 1.25 | 0.26396670401793 | 0.0030674846625767 | 7896 |
| 2025-04-29 | FATE | 1.175 | 0.25 | 0.00 | 8219 |
| 2025-04-30 | FATE | 1.295 | 0.25 | 0.33 | 8214 |
| 2025-05-01 | FATE | 1.22 | 0.26 | 0.00 | 8165 |
| 2025-05-02 | FATE | 1.31 | 0.26 | 0.00 | 8177 |
| 2025-05-05 | FATE | 1.16 | 0.26 | 0.00 | 8163 |
| 2025-05-06 | FATE | 0.95 | 0.26 | 0.28 | 8172 |
| 2025-05-07 | FATE | 0.9998 | 0.27 | 10.00 | 8393 |
| 2025-05-08 | FATE | 1.04 | 0.26 | 0.00 | 8392 |
| 2025-05-09 | FATE | 1.035 | 0.26 | 0.00 | 8401 |
| 2025-05-12 | FATE | 1.06 | 0.26 | 0.00 | 8399 |
| 2025-05-13 | FATE | 1 | 0.26 | 0.00 | 8400 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | FATE | 0.92 | 19.3 | - | -1.46 |
| 2025-04-15 | FATE | 1.12 | 19.3 | - | -1.46 |
| 2025-04-16 | FATE | 1.05 | 19.3 | - | -1.46 |
| 2025-04-17 | FATE | 1.11 | 19.3 | - | -1.46 |
| 2025-04-18 | FATE | 1.11 | 19.3 | - | -1.46 |
| 2025-04-21 | FATE | 1.26 | 19.3 | - | -1.46 |
| 2025-04-22 | FATE | 1.37 | 19.3 | - | -1.46 |
| 2025-04-23 | FATE | 1.33 | 19.3 | - | -1.46 |
| 2025-04-24 | FATE | 1.36 | 19.3 | - | -1.46 |
| 2025-04-25 | FATE | 1.28 | 19.3 | - | -1.46 |
| 2025-04-28 | FATE | 1.25 | 19.3 | - | -1.46 |
| 2025-04-29 | FATE | 1.17 | 19.3 | - | -1.46 |
| 2025-04-30 | FATE | 1.28 | 19.3 | - | -1.46 |
| 2025-05-01 | FATE | 1.24 | 19.3 | - | -1.46 |
| 2025-05-02 | FATE | 1.31 | 19.3 | - | -1.46 |
| 2025-05-05 | FATE | 1.17 | 19.3 | - | -1.46 |
| 2025-05-06 | FATE | 0.95 | 19.3 | - | -1.46 |
| 2025-05-07 | FATE | 1.00 | 19.3 | - | -1.46 |
| 2025-05-08 | FATE | 1.03 | 19.3 | - | -1.46 |
| 2025-05-09 | FATE | 1.04 | 19.3 | - | -1.46 |
| 2025-05-12 | FATE | 1.07 | 19.3 | - | -1.46 |
| 2025-05-13 | FATE | 1.00 | 19.3 | - | -1.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-15 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-16 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-17 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-18 | FATE | 0.32 | -12.74 | 15.82 |
| 2025-04-21 | FATE | 0.32 | -11.05 | 15.82 |
| 2025-04-22 | FATE | 0.32 | -11.05 | 15.82 |
| 2025-04-23 | FATE | 0.32 | -11.05 | 15.82 |
| 2025-04-24 | FATE | 0.32 | -11.05 | 15.82 |
| 2025-04-25 | FATE | 0.32 | -11.05 | 15.82 |
| 2025-04-28 | FATE | 0.32 | -11.08 | 15.06 |
| 2025-04-29 | FATE | 0.32 | -11.08 | 15.06 |
| 2025-04-30 | FATE | 0.32 | -11.08 | 15.06 |
| 2025-05-01 | FATE | 0.32 | -11.08 | 15.06 |
| 2025-05-02 | FATE | 0.32 | -11.08 | 15.06 |
| 2025-05-05 | FATE | 0.32 | -14.20 | 15.06 |
| 2025-05-06 | FATE | 0.32 | -14.20 | 15.06 |
| 2025-05-07 | FATE | 0.32 | -14.20 | 15.06 |
| 2025-05-08 | FATE | 0.32 | -14.20 | 15.06 |
| 2025-05-09 | FATE | 0.32 | -14.20 | 15.06 |
| 2025-05-12 | FATE | 0.32 | -13.00 | 12.89 |
| 2025-05-13 | FATE | 0.32 | -13.00 | 12.89 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.31
Avg. EPS Est. Current Quarter
-0.39
Avg. EPS Est. Next Quarter
-0.38
Insider Transactions
0.32
Institutional Transactions
-13
Beta
2.22
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
17
Growth Score
34
Sentiment Score
2
Actual DrawDown %
99.2
Max Drawdown 5-Year %
-99.4
Target Price
6.56
P/E
Forward P/E
PEG
P/S
8.41
P/B
0.36
P/Free Cash Flow
EPS
-1.65
Average EPS Est. Cur. Y
-1.46
EPS Next Y. (Est.)
-1.25
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1366.46
Relative Volume
0.9
Return on Equity vs Sector %
-82.1
Return on Equity vs Industry %
-65.2
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.19
EBIT Estimation
Fate Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 181
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
stock quote shares FATE – Fate Therapeutics, Inc. Stock Price stock today
news today FATE – Fate Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FATE – Fate Therapeutics, Inc. yahoo finance google finance
stock history FATE – Fate Therapeutics, Inc. invest stock market
stock prices FATE premarket after hours
ticker FATE fair value insiders trading